Company: CDT
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001246
Chunk: 28

Company: CDT Equity Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 1A
Chunk 28
---
, or challenged, and could result in substantial costs and diversion
of resources, which could adversely affect our business, financial condition, and operating results.

We
may be unable to continue to use the domain name that we use in our business or prevent third parties from acquiring and using domain
names that infringe on, are similar to, or otherwise decrease the value of our brand, trademarks, or service marks.

We
have registered the domain name that we use in our business. If we lose the ability to use that domain name, whether due to trademark
claims, failure to renew the applicable registration, or any other cause, we may be forced to market our business under a new domain
name, which could cause us substantial harm, or to incur significant expense in order to purchase rights to the domain name in question.
We may not be able to obtain preferred domain names outside the U.S. due to a variety of reasons, including because they are already
held by others. In addition, our competitors and others could attempt to capitalize on our brand recognition by using domain names similar
to our domain name. We may be unable to prevent third parties from acquiring and using domain names that infringe on, are similar to,
or otherwise decrease the value of our brand or our trademarks or service marks. Protecting, maintaining, and enforcing our rights in
our domain names may require litigation, which could result in substantial costs and diversion of resources, which could in turn adversely
affect our business, financial condition, and operating results.

We
may not be able to protect our intellectual property rights throughout the world.

Filing,
prosecuting, and defending patents on our clinical assets in all countries throughout the world would be prohibitively expensive. The
requirements for patentability may differ in certain countries, particularly developing countries. In addition, the laws of some foreign
countries do not protect intellectual property rights to the same extent as laws in the U.S. Consequently, we may not be able to prevent
third parties from practicing our inventions in all countries outside the U.S. Competitors may use our technologies in jurisdictions
where we have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to
territories where we have patent protection, but enforcement on infringing activities is inadequate. These products may compete with
our products, and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing. 

47

Many
companies have encountered significant problems in protecting and defending